Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 1997

View Archived Issues

Delta-opioid receptor ligands reported by SmithKline Beecham

Agents specific for dopamine D3 receptors described by Neurogen

Dual D2/beta2 agonists disclosed by Astra

SKB reveals metallo-beta-lactamase inhibitors

Preclinical results for N-3389 in emesis

Inhibitors of 5alpha-reductase from Pharmacia & Upjohn

Hypolipidemic triterpenes claimed by Leo

Lp-PLA2 inhibitors from SmithKline Beecham

Pierre Fabre prepares agents with antidopaminergic/antiserotonergic effects

Positive results from preclinical studies with darifenacin

Synthelabo develops alternative to AChE inhibitors for AD

Roche describes TK inhibitors for recurrent HSV infection

Preclinical and clinical profile of Pharmacia & Upjohn's tolterodine

Positive clinical results for desirudin in the prevention of thromboembolism

Antisense oligonucleotides for RSV infection

Anti-HIV antisense oligonucleotides from Hybridon evaluated in SCID mice

BTS-67582 in diabetes

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

Potential HSV-2 vaccine described by Aviron

Clinical results for intravaginal dextrin sulfate gel

New ganciclovir derivative from Norsk Hydro for HSV infections

Nacystelyn promising alternative to NAC for lung antioxidant therapy

Alanex and ICOS enter small-molecule drug discovery collaboration

Biovail: Q1 1997 highlights

GelTex: Q1 1997 highlights

CytRx initiates new phase II trial of purified RheothRx

Amgen: Q1 1997 highlights

Oncor submits supporting data to FDA on breast cancer test

Hyal's Oralease receives Emergency Drug Release status in Canada

Pharmaceutical companies expand genomics research

ArQule and Genzyme collaborate on the discovery and development of novel drug candidates

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...